[99mtc]tc-tecant1
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 23, 2022 (NCT05871320)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05871320 | Early Phase 1 (Phase 1) | Dec 23, 2022 | Jagiellonian University, Medical University Innsbruck, University of Ljubljana |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jagiellonian University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Medical University Innsbruck | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Ljubljana | Academic/Hospital | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1